Tradewind BioScience

OverviewSuggest Edit

Tradewind BioScience is a biotechnology company developing antibody therapeutics for ovarian cancer. It focuses on cancer stem cells, angiogenesis as well as anoikis.
TypePrivate
Founded2017
Websitetradewindbio.com

Latest Updates

Employees (est.) (Apr 2020)2
Cybersecurity ratingAMore

Tradewind BioScience Financials and Metrics

Summary Metrics

Founding Date

2017

Tradewind BioScience total Funding

$120 k

Tradewind BioScience latest funding size

$120 k

Time since last funding

3 years ago

Tradewind BioScience investors

Tradewind BioScience's latest funding round in January 2018 was reported to be $120 k. In total, Tradewind BioScience has raised $120 k
Show all financial metrics

Tradewind BioScience Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Tradewind BioScience Online and Social Media Presence

Embed Graph

Tradewind BioScience Frequently Asked Questions

  • When was Tradewind BioScience founded?

    Tradewind BioScience was founded in 2017.

  • How many employees does Tradewind BioScience have?

    Tradewind BioScience has 2 employees.

  • Who are Tradewind BioScience competitors?

    Competitors of Tradewind BioScience include DexTech Medical, OX2 Therapeutics and Gracell.